BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1725106)

  • 1. [Cyclic analogs of substance P. III. Cyclo (6(sup)gamma----oligomethylenediamine----11) substance P(6-11)-hexapeptides].
    Mutulis FK; Mutule IE; Maurops GKh; Bergmann Iu; Myshliakova NV; Strazda GM; Liepin'sh EE; Saulitis IuB; Grigor'eva VD; Balodis IuIu
    Bioorg Khim; 1991 Oct; 17(10):1412-23. PubMed ID: 1725106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Substance P. New cyclic analogs].
    Mutulis FK; Mutule IE; Maurops GKh; Sekatsis IP; Grigor'eva VD
    Bioorg Khim; 1985 Sep; 11(9):1276-8. PubMed ID: 2415137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological activity of NK-1 selective, N-backbone cyclic analogs of the C-terminal hexapeptide of substance P.
    Byk G; Halle D; Zeltser I; Bitan G; Selinger Z; Gilon C
    J Med Chem; 1996 Aug; 39(16):3174-8. PubMed ID: 8759639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and contractile activities of cyclic thrombin receptor-derived peptide analogues with a Phe-Leu-Leu-Arg motif: importance of the Phe/Arg relative conformation and the primary amino group for activity.
    Matsoukas JM; Panagiotopoulos D; Keramida M; Mavromoustakos T; Yamdagni R; Wu Q; Moore GJ; Saifeddine M; Hollenberg MD
    J Med Chem; 1996 Aug; 39(18):3585-91. PubMed ID: 8784457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformation-activity relationship in hexapeptides related to substance P.
    Elguero J; García-Antón JM; Goya P; Haro I; Martínez A; Reig F
    Arzneimittelforschung; 1989 Aug; 39(8):835-8. PubMed ID: 2479388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of interproton distances in peptides by two-dimensional nuclear Overhauser effect spectroscopy (NOESY). Conformation of a cyclic analog of substance P in a solution].
    Saulitis IuB; Liepin'sh EE
    Bioorg Khim; 1987 Feb; 13(2):168-76. PubMed ID: 2437930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cyclic analogs of substance P. I. Cyclo(11----epsilon 5)-[Lys5] substance P-(5-11)].
    Maurops GKh; Mutulis FK; Rozite SKh; Myshliakova NV; Svirskis ShV
    Bioorg Khim; 1987 Dec; 13(12):1619-28. PubMed ID: 2453193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic pentapeptides of chiral sequence DLDDL as scaffold for antagonism of G-protein coupled receptors: synthesis, activity and conformational analysis by NMR and molecular dynamics of ITF 1565 a substance P inhibitor.
    Porcelli M; Casu M; Lai A; Saba G; Pinori M; Cappelletti S; Mascagni P
    Biopolymers; 1999 Aug; 50(2):211-9. PubMed ID: 10380345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Synthesis of cyclic and non-cyclic tachykinin partial sequences. 2. Synthesis of the homocyclic substance P(6-11) hexapeptide].
    Neubert K; Hartrodt B; Mehlis B; Rüger M; Bergmann J; Lindau J; Jakubke HD; Barth A
    Pharmazie; 1985 Aug; 40(8):532-5. PubMed ID: 2417264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Synthesis of cyclic and cyclically branched tachykinin partial sequences. 1. Synthesis of the homodet-cyclic eledoisin(6-11)-hexapeptide].
    Neubert K; Bergmann J; Mansfeld J; Hartrodt B; Barth A; Jakubke HD
    Pharmazie; 1985 Jul; 40(7):456-9. PubMed ID: 2413489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solution conformation of a cyclic neurokinin antagonist: a NMR and molecular dynamics study.
    Zhang M; Quinn TP; Wong TC
    Biopolymers; 1994 Sep; 34(9):1165-73. PubMed ID: 7948730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformations of psi [CH2NH] pseudopeptides. Cyclo[Gly-Pro psi [CH2NH]Gly-D-Phe-Pro]-TFA and cyclo[Gly-Pro psi [CH2NH]Gly-D-Phe-Pro].
    Ma S; Spatola AF
    Int J Pept Protein Res; 1993 Feb; 41(2):204-6. PubMed ID: 8458694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformationally constrained tachykinin analogs which are selective ligands for the eledoisin binding site.
    Cascieri MA; Chicchi GG; Freidinger RM; Colton CD; Perlow DS; Williams B; Curtis NR; McKnight AT; Maguire JJ; Veber DF
    Mol Pharmacol; 1986 Jan; 29(1):34-8. PubMed ID: 2418347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synthesis and biological activity of a lysine-containing cyclic analog of [Leu5]enkephalin].
    Bobrova IV; Abissova NA; Rozental' GF; Nikiforovich GV; Chipens GI
    Bioorg Khim; 1985 Nov; 11(11):1457-67. PubMed ID: 3004508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformations of cyclic octapeptides. 4. Diastereomers of cyclo(Gly-Pro-Phe-Ala-Asn-Ala-Val-Ser).
    Vishwanath CK; Go A; Parameswaran KN; Wang YS; Kopple KD
    Int J Pept Protein Res; 1986 Oct; 28(4):428-36. PubMed ID: 3793373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Synthesis of a cyclic enkephalin analog with prolonged action].
    Bobrova IV; Myshliakova NA; Papsuevich OS; Vosekalna IA; Mekshun EI
    Bioorg Khim; 1995 Apr; 21(4):275-81. PubMed ID: 7786318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and opioid activity of side-chain-to-side-chain cyclic dynorphin A-(1-11) amide analogues cyclized between positions 2 and 5. 1. Substitutions in position 3.
    Vig BS; Murray TF; Aldrich JV
    J Med Chem; 2004 Jan; 47(2):446-55. PubMed ID: 14711314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic hexapeptides bearing carboxyl groups. Interaction with metal ions and lipid membrane.
    Ozeki E; Miyazu T; Kimura S; Imanishi Y
    Int J Pept Protein Res; 1989 Aug; 34(2):97-103. PubMed ID: 2807735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of cyclic and acyclic partial retro-inverso modified enkephalins.
    Berman JM; Goodman M
    Int J Pept Protein Res; 1984 Jun; 23(6):610-20. PubMed ID: 6469459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synthesis and study of cyclic and linear analogs of neurotensin].
    Grinshteĭne IV; Myshliakova NV; Vegner RE; Vosekalna IA; Gaĭlite EA
    Bioorg Khim; 1985 Dec; 11(12):1589-97. PubMed ID: 4084322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.